Current Edition

Current Features

How Involved Should Biopharma CEOs Be In Outsourcing Activities?

When outsourcing drug development and manufacturing, how involved should the CEOs of emerging biopharma be in the requisite day-to-day activities and processes? Louis Garguilo interviews …

Continue Reading →
Current Features

5 Drugs Facing Key Patent Expirations and Potential Generic Entry from December 2021 – February 2022

A challenge in anticipating generic entry is elucidating which patents and regulatory protections constrain generic entry. Yali Friedman at DrugPatentWatch, presents a set of an …

Continue Reading →
Current Features

Contamination Control Strategy

Regulatory bodies expect that pharmaceutical companies have a Contamination Control Strategy (CCS) in place that outlines the control of contamination of utilities, manufacturing systems and …

Continue Reading →
Current Features

Digitisation versus Digitalisation – Understanding the Difference and the Role of LIMS in Achieving Both

The system infrastructure for the creation, storage and management of electronic data has to be in place. If this isn’t the case, then completing a …

Continue Reading →
Current Features

Predicting Drug Bioavailability with the Modern-day Toolkit

Bioavailability is defined as the fraction of drug reaching systemic circulation following absorption in the gut and first-pass metabolism in the liver. Accurately predicting the …

Continue Reading →